SCOPE OPHTHALMICS TO LAUNCH Tranquileyes™ ‘MOIST HEAT’ TREATMENT FOR OCULAR SURFACE DISEASES AT 100% OPTICAL SHOW

[LONDON, 7th – 9th February 2015] Scope Ophthalmics, a leading player in the UK ocular surface disease market makes its debut at the trade show, 100% Optical - 7 to 9 February - and launches the Tranquileyes™ innovation for dry eye disease management.

Using specially-designed goggles, warm water and reusable gel pack technology, this first-of-its-kind treatment enables patients to create a safe, soothing, moist-heat compress; an alternative to dry heat products. Moist heat loosens the oils in the meibomian glands, penetrating deeply to help hydrate the eyelid and surrounding skin, and promote circulation. By contrast, dry heat pulls moisture away from the eyelid and the sensitive surrounding skin, negating the anti-aging requirements of many women, and increasing the instability of the tear film. Studies1 have shown that applying effective moist heat to the eyelids is beneficial for all levels of meibomian gland dysfunction (MGD). Tranquileyes™ is available as 3 products: Instants (ideal for travelling / out of home use), Beads (ideal for home use) and Advanced (a hybrid of both).

Tom Freyne, Commercial Director at Scope Ophthalmics explains, “We’re very excited to be at 100% Optical for the first time, and to launch Tranquileyes™ which will provide eye care practitioners with a more sophisticated way to help people affected in the UK to manage their dry eye or MGD. This is a growing market as our population ages, so it’s important to be able to offer a good range of choice in terms of safe and effective innovations.”

Dry Eye Disease (DED) can affect people of any age, although risk increases with age. It is estimated that up to one in every three people over the age of 65 experiences problems with dry eyes, according to NHS Choices2. MGD is thought to be the leading cause of dry eye disease; a chronic disease, it is usually caused by obstruction of the secretory meibomian glands. The subsequent reduction of gland secretion results in a decreased amount of lipids in the tear film. This results in faster evaporation of the tear film and thus an evaporative dry eye. MGD alone is responsible for about 60% of all cases, in combination with aqueous deficiency for a further 20% of dry eyes3.

EXPERT EDUCATIONAL EVENTS

Demodex: at the route of the problem

This interactive workshop will outline the clinical presentation of blepharitis and demodex mites and clearly explain the appropriate steps required to successfully manage this condition in high street practice, involving some new approaches. Excellent video footage from the presenters practice and real life demonstrations will help delegates appreciate the key clinical signs and the latest options they have available to treat blepharitis and demodex mites.

Supported by Scope Ophthalmics.

• CET Education: Demodex Blepharitis
• Speaker : Ian Cameron, Optometrist, DipTP (IP); Cameron Optometry, Edinburgh
• Day: Saturday, 7th February, 2015
• Time: 1pm – 2pm
• Location: Lens Hub  (adjacent to 100% Lenses)

The workshop is being held as part of Scope Ophthalmics’ consistent focus on education as a cornerstone of its customer service for 2015 and beyond. Also attending Scope’s stand will be Scope Ophthalmics’ nutritionist, Amy Liddell, who will highlight the benefits of Scope’s Omega Eye omega-3 essential fatty acid supplement for optimal eye health.PRESS RELEASE - Scope Ophthalmics launches Tranquileyes at 100 Optical show

Amy holds a BSc Hons in Biology from Brighton University, a Dip Nutritional Therapy and Dip Naturopathy from the College of Naturopathic Medicine. Amy has also worked as a Nutritionist for a young parents charity, and devised and taught on an accredited OCN course in Health and Nutrition. Amy has also practiced as a health coach for a private medical company, carrying out health checks in corporate settings, and as a health and wellbeing advisor – setting up health development plans and programmes in corporate settings to improve staff productivity. Amy will be on the stand onSaturday and Sunday to answer all questions relating to Omega 3s, and how they are used in treating chronic Dry Eye Disease (DED).

For all enquiries, including interview opportunities, please contact:

Heather Mullins at ROAD Communications, heather@roadcommunications.co.uk

Tel: +44 (0)20 8995 5832 M: +44 (0)7545 536147 

Scope Ophthalamics is an innovative and fast-growing optical company offering dry eye and blepharitis products in the UK and Ireland. All of its products have had long-term success with patients worldwide. Key product focuses include preservative-free eye drops which contain the ingredient hyaluronic acid. In 2014, Scope successfully launched BlephEx™ as the first and only clinician treatment for blepharitis. The company maintains a major focus on training, customer service, innovation and relationships with key opinion leaders. 

Tags: